Form 144 | Mirum Pharmaceuticals(MIRM.US) Officer Proposes to Sell 1.07 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Jul 1, $Mirum Pharmaceuticals(MIRM.US)$ Officer LARA LONGPRE intends to sell 30,559 shares of its common stock on Jul 1, with a total market value of approximately $1.07 millio

Futu NewsJul 2 05:40

JMP Securities Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $68

JMP Securities analyst Jonathan Wolleben maintains $Mirum Pharmaceuticals(MIRM.US)$ with a buy rating, and maintains the target price at $68.According to TipRanks data, the analyst has a success rate

Futu NewsJun 29 01:31 · Ratings

HC Wainwright & Co. Reiterates Buy on Mirum Pharmaceuticals, Maintains $66 Price Target

HC Wainwright & Co. analyst Ed Arce reiterates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and maintains $66 price target.

BenzingaJun 29 01:26

Mirum Pharmaceuticals Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/28/2024 104.21% HC Wainwright & Co. $66 → $66 Reiterates Buy → Buy 06/20/2024 104.21% Stifel $48 → $66

BenzingaJun 29 01:23

H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $66

H.C. Wainwright analyst Ed Arce maintains $Mirum Pharmaceuticals(MIRM.US)$ with a buy rating, and maintains the target price at $66.According to TipRanks data, the analyst has a success rate of 38.9%

Futu NewsJun 29 00:32 · Ratings

Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $64

Citi analyst David Lebovitz maintains $Mirum Pharmaceuticals(MIRM.US)$ with a buy rating, and maintains the target price at $64.According to TipRanks data, the analyst has a success rate of 50.2% and

Futu NewsJun 28 20:33 · Ratings